Avid Bioservices Inc (CDMO)

[sunstar]

Jazz, PS is looking, more and more, like a universal marker of disease in humans.

First it was cancer: PS, as we now know, is exposed on dead, dying and cancer stressed cells.

What a surprise to find that the same PS phenomenon was occurring also as a result of infection by all these serious disease causing enveloped viruses: HIV, Flu, Hep C, deadly Ebola and the many others in this group.

Bavituximab has already been shown to successfully target PS on many different tumor types and all the enveloped viruses tested to date.

These diseases, alone, constitute a massive portion of human medicine: many, maybe most, of the cancers that kill us. It’s very likely that bavi targets all the enveloped viruses too, because they all expose PS.

Think very carefully about how big of a market we’re talking about.

It’s starting to look like we will be finding even more diseases that expose PS. Many of these outside papers that Jazz has been showing the board are mentioning these: Malaria, Leishmania. (That’s when your dog turns on you during a walk in the park)

It makes total sense, when you think about it, that when disease agents start attacking your cells: killing them, that they would be dying and exposing PS.

This is why bavituximab is going to be SO BIG.

sunstar